AI filing briefs · archive

8-K filings in March 2025, explained

442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

5 of 442 briefs match

newest first · times in ET

Acadia Healthcare prices $550 million 7.375% senior notes due 2033

Neutral financing Written later 1.012.038.01

Acadia Healthcare Company entered into an indenture dated March 10, 2025 for $550 million of 7.375% senior unsecured notes maturing March 15, 2033, sold in a private offering to qualified institutional and non-U.S. buyers. The company said it will use the proceeds to prepay outstanding borrowings under its senior secured revolving line of credit, which replaces floating-rate revolver debt with fixed-rate notes and adds $550 million of long-term debt to its balance sheet.

  • Notes total $550 million in principal, up $50 million from the $500 million launched March 5, 2025, and were offered at 100% of principal.
  • Interest of 7.375% per year is payable semi-annually on March 15 and September 15, starting September 15, 2025.
  • The company may redeem the notes on or after March 15, 2028, and may redeem up to 40% before then using equity offering proceeds at 107.375% of principal.
  • The indenture limits additional debt, liens, dividends, stock buybacks, asset sales and mergers, and the offering was expected to close March 10, 2025.
Read the filing on SEC.gov ↗
IQVIQVIA HOLDINGS INC. Mar 10, 4:30 PM ET

IQVIA amends credit agreement, cuts rate on Term B-4 loans to SOFR plus 1.75%

Neutral financing Written later 1.012.03

IQVIA Holdings entered into Amendment No. 4 to its Fifth Amended and Restated Credit Agreement on March 10, 2025. The amendment creates new term B dollar loans used to refinance Term B-4 Dollar Loans at a lower margin and to repay Term B-2 Euro Loans in full. The filing does not state the loan amounts, so the size of the change in borrowing costs cannot be determined from it.

  • Term B-4 Dollar Loans refinanced; margin cut from SOFR plus 2.00% to SOFR plus 1.75% per annum
  • Term B-2 Euro Loans to be repaid in full under the amendment
  • Amendment dated March 10, 2025; administrative agent is Bank of America, N.A.
  • Filing does not disclose principal amounts of the new or repaid loans
Read the filing on SEC.gov ↗
CMECME GROUP INC. Mar 10, 4:12 PM ET

CME Group completes $750 million 4.400% notes offering due 2030

Neutral financing Written later 1.01

CME Group completed a $750 million offering of 4.400% notes due 2030 on March 10, 2025, under its shelf registration. The company plans to use the net proceeds, with cash on hand, to retire its $750 million of 3.00% notes due 2025 and for general corporate purposes. The deal refinances existing debt and adds new debt, with interest payable each March 15 and September 15 beginning September 15, 2025.

  • Notes: $750 million aggregate principal, 4.400%, due 2030, offered at 99.573% of principal
  • Proceeds plus cash on hand intended to retire all $750 million of 3.00% notes due 2025
  • Interest payable March 15 and September 15, starting September 15, 2025; change of control repurchase at 101% of principal
Read the filing on SEC.gov ↗

Bread Financial closes $400 million subordinated notes offering due 2035 at 8.375%

Neutral financing Written later 1.012.03

Bread Financial Holdings closed a $400 million offering of 8.375% fixed-rate reset subordinated notes due 2035 on March 10, 2025. The notes are unsecured, rank junior to the company's senior debt, and carry a fixed rate until June 15, 2030, after which the rate resets to the five-year U.S. Treasury rate plus 430 basis points.

  • Principal amount: $400 million; maturity June 15, 2035
  • Fixed 8.375% interest until the Reset Date of June 15, 2030, then five-year U.S. Treasury Rate plus 430 basis points
  • Interest paid semiannually on June 15 and December 15, starting June 15, 2025
  • Company may redeem in whole on June 17, 2030, or within 90 days after a regulatory capital treatment event, subject to regulatory approval
Read the filing on SEC.gov ↗
SHWSHERWIN WILLIAMS CO Mar 10, 11:33 AM ET

Sherwin-Williams extends $75 million of credit commitments to June 2030

Neutral financing Written later 1.012.03

Sherwin-Williams entered into Amendment No. 10 to its credit agreement with Goldman Sachs Bank USA as administrative agent. The primary purpose is to extend the maturity of $75 million of borrowing and letter of credit commitments from June 20, 2025 to June 20, 2030, which pushes out the timing of that portion of the company's available credit.

  • Amendment No. 10 dated March 10, 2025 amends the Credit Agreement dated August 2, 2021
  • $75 million of commitments for borrowing and letters of credit extended from June 20, 2025 to June 20, 2030
  • Goldman Sachs Mortgage Company is issuing bank; lenders receive customary fees for financial services
  • Full text filed as Exhibit 4.1
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.